Abstract:Drug targets are biological macromolecules that bind drug molecules in vivo. Therefore, the system-wide identification of drug targets plays a vital role in fully understanding the mechanism of drug action, efficacy, and side effects. The unbiased screening of drug targets may accelerate the process of drug discovery and candidate screening. Mass spectrometry is a key tool for large-scale protein identification and accurate quantification owing to its high acquisition speed, resolution, and sensitivity. Mass spectrometry-based proteomics has been widely used for drug-target screening. It can systematically identify the protein-target landscape of a drug and elucidate drug-protein interactions. Commonly used drug-target characterization methods, such as labeling-based affinity enrichment, require the chemical derivatization of drug molecules, which is not only time-consuming but may also affect the affinity of the drug towards its targets. Furthermore, the spatial effects of the derivatization groups may block interactions between the drug and its targets. Considering the disadvantages of affinity-enrichment methods, strategies that do not require chemical derivatization have received widespread attention. Proteins may undergo denaturation, unfolding, and precipitation under different conditions such as high temperatures, extreme pH, denaturants, and mechanical stress. Binding to small-molecule drugs may alter the folding balance of target proteins. The conformational stability of target proteins can be stabilized by binding with drugs, and protein-drug complexes are more resistant than free proteins to the precipitation induced by different conditions. Based on this mechanism, various large-scale drug-target identification methods using protein precipitation have been developed by combining proteomics and mass spectrometry analysis, including thermal proteome profiling and solvent-, mechanical stress-, and pH-induced protein precipitation. These methods have been successfully applied to the characterization of small-molecule drug targets. In this review, we describe the protein precipitation-based methods used for the high-throughput discovery of drug targets and elucidation of the interactions between drugs and proteins in the past decade. We also summarize the characteristics of each method and discuss their application potential in drug-efficacy evaluation and drug discovery.

STREAMLINED PROTEOME-WIDE IDENTIFICATION OF DRUG TARGETS INDICATES ORGAN-SPECIFIC ENGAGEMENT

Methods to Profile the Macromolecular Targets of Small Compounds.

Learning the Drug Target-Likeness of A Protein

An Integrated Structure- and System-Based Framework to Identify New Targets of Metabolites and Known Drugs

Identifying The Proteins To Which Small-Molecule Probes And Drugs Bind In Cells

Label-free target protein characterization for small molecule drugs: recent advances in methods and applications

Chemical Proteomics to Identify Molecular Targets of Small Compounds

Integrated Protein Solubility Shift Assays for Comprehensive Drug Target Identification on a Proteome-Wide Scale

Proteomic methods for drug target discovery

Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC.

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

Target protein identification in live cells and organisms with a non-diffusive proximity tagging system

High throughput proteome screening for novel drug targets

High-throughput Drug Target Discovery Using a Fully Automated Proteomics Sample Preparation Platform.

Exploiting Chemical Probes for Identifying Drug Target Proteins

Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification

Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.

A Proteomic Platform to Identify Off-Target Proteins Associated with Therapeutic Modalities That Induce Protein Degradation or Gene Silencing

[Recent advances in protein precipitation-based methods for drug-target screening]

Solvent-induced protein precipitation for drug target discovery on proteomic scale.

Proteome integral solubility alteration via label‐free DIA approach (PISA‐DIA), game changer in drug target deconvolution